Gu Peng, Zhao Xiyan, Zhang Zheng, Zhang Bao, Du Ying, Jia Yanqing, Tang Hao, Wang Yi, Wen Tianlin, Jia Zhiwei, Wu Yaohong
Department of Orthopedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Clinical Medical School, Qinghai University, Xining, Qinghai, China.
Eur J Med Res. 2025 Jul 16;30(1):633. doi: 10.1186/s40001-025-02900-0.
Inflammation is a crucial factor in the development of both osteoporosis and sleep disturbances; however, the mechanisms that connect these two conditions are not yet fully understood. This study aims to investigate the relationship among inflammation, osteoporosis, and sleep disturbances, and to assess whether osteoporosis acts as a mediating factor between inflammation and sleep disturbances.
This study conducted a cross-sectional analysis utilizing data from participants aged 50 and older, sourced from the NHANES database for the years 2005-2010 and 2017-2018. The primary objective was to investigate the associations among inflammatory markers, the Dietary Inflammatory Index (DII), osteoporosis, and sleep disturbances. All participants underwent measurement of inflammatory markers, including C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR). Additionally, DII scores were computed to assess dietary inflammation. To account for potential confounding variables, such as age, sex, and body mass index (BMI), we conducted multivariable regression analyses.
The results demonstrated that the 'osteoporosis with sleep disturbances' group exhibited significantly higher CRP levels and DII scores but lower NLR levels compared to the 'without osteoporosis and sleep disturbances' group. Among the four groups, two groups without sleep disturbances showed notably lower CRP levels. After controlling for potential confounding variables, we found a positive correlation among inflammatory markers, osteoporosis, and sleep disturbances. Notably, sex (with males as the reference group) moderated the relationship between inflammatory markers and sleep disturbances, demonstrating an adjusted effect size of - 0.430 for NLR (interaction p value = 0.008) and - 0.163 for CRP (interaction p value = 0.012). Additionally, a non-linear relationship was observed between NLR and sleep disturbances, as well as between NLR, DII, and osteoporosis. Mediation analysis indicated that osteoporosis partially mediates the effect of DII on sleep disturbances, accounting for 5.4574% of the total effect (p = 0.002).
Men may exhibit a reduced resistance to inflammation-induced sleep disturbances in comparison to women. An increase in the DII may serve as a risk factor for both osteoporosis and sleep disturbances. Furthermore, osteoporosis partially mediates the relationship between the DII and sleep disturbances.
炎症是骨质疏松症和睡眠障碍发展中的一个关键因素;然而,连接这两种情况的机制尚未完全明确。本研究旨在调查炎症、骨质疏松症和睡眠障碍之间的关系,并评估骨质疏松症是否作为炎症与睡眠障碍之间的中介因素。
本研究利用2005 - 2010年和2017 - 2018年美国国家健康与营养检查调查(NHANES)数据库中50岁及以上参与者的数据进行横断面分析。主要目的是研究炎症标志物、饮食炎症指数(DII)、骨质疏松症和睡眠障碍之间的关联。所有参与者均接受了炎症标志物的测量,包括C反应蛋白(CRP)和中性粒细胞与淋巴细胞比值(NLR)。此外,计算DII得分以评估饮食炎症。为了考虑潜在的混杂变量,如年龄、性别和体重指数(BMI),我们进行了多变量回归分析。
结果表明,与“无骨质疏松症和睡眠障碍”组相比,“伴有睡眠障碍的骨质疏松症”组的CRP水平和DII得分显著更高,但NLR水平更低。在四组中,两组无睡眠障碍的组CRP水平明显更低。在控制潜在的混杂变量后,我们发现炎症标志物、骨质疏松症和睡眠障碍之间存在正相关。值得注意的是,性别(以男性作为参照组)调节了炎症标志物与睡眠障碍之间的关系,NLR的调整效应大小为 - 0.430(交互作用p值 = 0.008),CRP的调整效应大小为 - 0.163(交互作用p值 = 0.012)。此外,观察到NLR与睡眠障碍之间以及NLR、DII和骨质疏松症之间存在非线性关系。中介分析表明骨质疏松症部分介导了DII对睡眠障碍的影响,占总效应的5.4574%(p = 0.002)。
与女性相比,男性可能对炎症诱导的睡眠障碍抵抗力较低。DII升高可能是骨质疏松症和睡眠障碍的危险因素。此外,骨质疏松症部分介导了DII与睡眠障碍之间的关系。